Register for free to
view the full innovation profile.
It has the ability to co-inject peptide with insulin to increase insulin sensitivity and could lead to use of less insulin being required to generate desired effects
About
Summary The element chromium (Cr) can act as a pharmaceutical agent at high does although it is not an essential trace element. This invention is a novel low molecular weight peptide that binds with chromium. This peptide bound with chromium interacts with other biomolecules, such as insulin receptor, to increase insulin sensitivity. It has the potential to treat symptoms of conditions related to improper lipid and carbohydrate metabolism.